In humans, CD19 mutations result in severe immunodeficiency, whereas CD19 overexpression in mice leads to defects in early B cell development, hyperresponsiveness to stimulation, and autoimmune-like phenotypes (67). This evidence concerns the gene CD19 and immunodeficiency disease.